CN103834714A - In vitro research on inhibition effects of hydrogen peroxide on surviving promotion performance of Insulin-like Growth Factor1 (IGF-1) - Google Patents
In vitro research on inhibition effects of hydrogen peroxide on surviving promotion performance of Insulin-like Growth Factor1 (IGF-1) Download PDFInfo
- Publication number
- CN103834714A CN103834714A CN201210474838.5A CN201210474838A CN103834714A CN 103834714 A CN103834714 A CN 103834714A CN 201210474838 A CN201210474838 A CN 201210474838A CN 103834714 A CN103834714 A CN 103834714A
- Authority
- CN
- China
- Prior art keywords
- igf
- cell
- hydrogen peroxide
- surviving
- dmem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of medicine, and discloses inhibition effects of hydrogen peroxide on surviving promotion performance of IGF-1. According to an in vitro research on inhibition effects of hydrogen peroxide on surviving promotion performance of IGF-1, PC12 cell (rat adrenal pheochromocytoma) is taken as a research object, a serum deprived group is taken as a model, IGF-1 is used for protecting PC12 from damages caused by serum deprivation, and promoting surviving of PC12 cell; H2O2 (hydrogen peroxide) of different concentration is added before treatment using IGF-1, MTT (methyl thiazolyl tetrazolium method) is used for detecting cell viability, and it is shown by the results that serum deprivation is capable of reducing cell viability obviously, IGF-1 is capable of protecting PC12 cell from damages caused by serum deprivation in a dose-dependent manner, and H2O2 is capable of inhibiting the surviving promotion performance of IGF-1 in a dose-dependent manner.
Description
Technical field
The invention belongs to medical technical field, relate to the mechanism that a kind of hydrogen peroxide suppresses PC12 cell viability, suppressed the short survival function of IGF-1.
Background technology
Aerobic cell can produce a series of reactive oxygen specieses (reactive oxygen species, ROS) in metabolic process, comprises superoxide anion [O
2 -], hydrogen peroxide [H
2o
2] and hydroxy radical qiao [OH] etc., their character is extremely active, can seriously damage the biomacromolecules such as microbial film, enzyme, protein and nucleic acid, existing research shows that the generations of numerous disease such as tumour, aging, cardiovascular and cerebrovascular and the existence of ROS have close ties.Along with the development of Free Radical Biology research, people recognize apoptosis and the propagation that ROS can some tumour cell of double regulation control gradually, and have found the internal association between active oxygen radical and cell signalling.Current research discovery, the active oxygen radical of lower concentration can affect a series of signal transduction pathway.Active oxygen radical in body the life and death balance of body cell by its concentration adjustment, except causing apoptosis, downright bad function, the ROS of lower concentration widely physiological significance is the promotion of its activation to transcription factor and on cell proliferation, differentiation.
Insulin-like growth factor-i (Insulin-like Growth Factor-1, IGF-1) be a kind of at the synthetic nutritional factor of liver, its biological function is extensive, there is the neurocyte proliferation of promotion, differentiation in central nervous system, promote the function of neuronal survival, and these biological functions all rely on its high-affinity receptor IGF-1R and bring into play.The transgenic mice compared with normal Mouse Weight that IGF-1R knocks out reduces approximately 45%, after birth, die from the heteroplasia of many organs, wherein nervous system development defect is the major reason that causes transgenic mice death, and this demonstrates the vital role of IGF-1 in central nervous system.Short neuronal survival is that IGF-1 is at one of most important biological function of central nervous system, external much research has shown that IGF-1 can resist the cell injury that many reasons causes, the Neuron Apoptosis causing as serum deprivation, the neurotoxicity that 6-hydroxydopamine causes, the apoptosis of low potassium induction, the nerve excitability toxicity of cerebral ischemia and L-glutamic acid etc.
Summary of the invention
The object of the invention is to inquire into the effect of hydrogen peroxide to the short survival function of IGF-1, provide a kind of hydrogen peroxide to reduce the mechanism of PC12 cell survival, cell death inducing.Take PC12 cell (Clonal Rat Pheochromocytoma oncocyte) as research object, to deprive serum as model, IGF-1(insulin-like growth factor-i) avoid depriving for the protection of PC12 the damage that serum causes, promote PC12 cell survival.And give before IGF-1 processes to add in advance the H of different concns
2o
2(hydrogen peroxide), MTT(thiazole blue laws) detect cell viability, result shows the survival ability of depriving serum and can significantly reduce cell, and the damage that serum brings is deprived in the protection PC12 cell antagonism that IGF-1 can dose-dependently, and H
2o
2this short survival function of inhibition IGF-1 that can dose-dependently.
Embodiment
The concrete operation steps of the present invention is as follows:
1, the cultivation PC12 cell derived adult rat adrenal tissue medullary substance pheochromocytoma of cell, is widely used in the in vitro study of nervous system disorders, is incubated in the DMEM substratum that contains 5%FBS, 5%HS, 1%PSA, in 37 ℃, 5%CO
2under condition, cultivate, after cell covers with, use containing the DMEM culture medium inoculated of 1%FBS, 1%PSA and in 96 holes with after 24 hours, cell is processed.
2, before cell processing, first cell is changed to liquid and become pure DMEM 1hour, then normal group changes DMEM+1.5% FBS into, deprive serum model group and adopt pure DMEM, IGF-1 administration group gives (2.5ng/ml, 25.0ng/ml, 50.0ng/ml, 100.0ng/ml) IGF-1, continues to cultivate mtt assay after 24 hours and detects cell viability; Investigate H
2o
2effect to the short survival of IGF-1 function is the H that first uses different concns (10 μ M, 30 μ M, 100 μ M, 200 μ M, 400 μ M)
2o
2pretreatment cell 1 hour, then add IGF-1 to process.
3, MTT detect cell viability by cell with 0.5 × 10
5/ ml is inoculated in 96 well culture plates, and 100 μ l/ holes, at 37 ℃ of 5% CO
2under condition, after overnight incubation, give different treatment factor by grouping requirement, establish 8 parallel multiple holes for every group.Cultivate after 24 h, it is the MTT 100 μ l of 0.5 mg/ml that every hole adds final concentration, then cultivates 5 h, nutrient solution inclines, add DMSO 100 μ l/ holes, after the crystallization of first a ceremonial jade-ladle, used in libation is dissolved completely, read every hole absorbancy (A) at wavelength 570nm place with enzyme linked immunological instrument.The mean of getting 8 hole A values calculates cell survival rate=(test holes A average/control wells A average) × 100 % by formula.Repeat 3 times.
Claims (5)
1. hydrogen peroxide suppresses the in vitro study of the short survival of IGF-1 function, it is characterized in that take PC12 cell (Clonal Rat Pheochromocytoma oncocyte) as research object, to deprive serum as model, investigate IGF-1(insulin-like growth factor-i) short survival function to PC12 cell, its restraining effect to the short survival of IGF-1 function of different concns hydrogen peroxide Study on pretreatment.
2. in vitro study according to claim 1, it is characterized in that research object is PC12 cell, the cell density that mtt assay detects cell viability is 5000-8000/ hole, normal group is DMEM (basic medium)+1.5% FBS (foetal calf serum), deprive the DMEM that serologic group is equivalent, IGF-1 administration group is the IGF-1+DMEM of 12.5ng/ml, 25.0ng/ml, 50.0ng/ml, 100.0ng/ml, after administration, is the CO that 37 ℃, relative humidity are 95% in temperature
2in incubator, continue to cultivate 24 hours.
3. in vitro study according to claim 1, is characterized in that investigating the H that make used time different concns of hydrogen peroxide to the short survival function of IGF-1
2o
2(10 μ M, 30 μ M, 100 μ M, 200 μ M, 400 μ M) pretreatment cell 1 hour, and then add IGF-1, continue to cultivate mtt assay after 24 hours and detect cell viability.
4. according to the study in vitro described in claim 2,3, it is characterized in that for the basic medium compound method of cell cultures being: one bag of high glycoform DMEM powder is dissolved in to the ultrapure water of 500~800 mL, separately adds 5.95 g HEPES and 3.7 g NaHCO
3, magnetic agitation is dissolved dry powder completely, is settled to 1000 mL, regulates pH value to 7.2~7.4, under aseptic condition, is packing after the filtering with microporous membrane degerming of 0.22 μ m with aperture, placement storage in 4 ℃ of refrigerators.
5. according to the study in vitro described in claim 2,3, it is characterized in that for detection of the mtt assay compound method of cell viability as follows: under aseptic condition, take a certain amount of MTT powder, it is 5 mg/mL that PBS is dissolved to concentration, separating device-80 ℃ storage is for subsequent use, before using, is diluted to 0.5 mg/mL with DMEM.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210474838.5A CN103834714A (en) | 2012-11-21 | 2012-11-21 | In vitro research on inhibition effects of hydrogen peroxide on surviving promotion performance of Insulin-like Growth Factor1 (IGF-1) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210474838.5A CN103834714A (en) | 2012-11-21 | 2012-11-21 | In vitro research on inhibition effects of hydrogen peroxide on surviving promotion performance of Insulin-like Growth Factor1 (IGF-1) |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103834714A true CN103834714A (en) | 2014-06-04 |
Family
ID=50798608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210474838.5A Pending CN103834714A (en) | 2012-11-21 | 2012-11-21 | In vitro research on inhibition effects of hydrogen peroxide on surviving promotion performance of Insulin-like Growth Factor1 (IGF-1) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103834714A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107488632A (en) * | 2017-10-17 | 2017-12-19 | 湖南师范大学 | A kind of abandoned optical discs recoverying and utilizing method and the method that PC12 cells are cultivated using the CD after recovery |
CN110144049A (en) * | 2019-05-31 | 2019-08-20 | 黄河科技学院 | A kind of copper-terephthalic acid (TPA) nanoparticle, preparation method and application |
-
2012
- 2012-11-21 CN CN201210474838.5A patent/CN103834714A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107488632A (en) * | 2017-10-17 | 2017-12-19 | 湖南师范大学 | A kind of abandoned optical discs recoverying and utilizing method and the method that PC12 cells are cultivated using the CD after recovery |
CN110144049A (en) * | 2019-05-31 | 2019-08-20 | 黄河科技学院 | A kind of copper-terephthalic acid (TPA) nanoparticle, preparation method and application |
CN110144049B (en) * | 2019-05-31 | 2021-03-30 | 黄河科技学院 | Copper-terephthalic acid nano-particle, preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Skemiene et al. | Anthocyanins block ischemia-induced apoptosis in the perfused heart and support mitochondrial respiration potentially by reducing cytosolic cytochrome c | |
Zhang et al. | Neuroprotective effect of pretreatment with ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus | |
McLimans | The gaseous environment of the mammalian cell in culture | |
CN103710290B (en) | Come from probiotic bacterium lactobacillus rhamnosus hsryfm1301 and the application thereof of Bama of Guangxi Changshou village | |
CN103834714A (en) | In vitro research on inhibition effects of hydrogen peroxide on surviving promotion performance of Insulin-like Growth Factor1 (IGF-1) | |
CN104140952B (en) | hyaluronidase and preparation method thereof | |
CN104140950A (en) | Cleavage culture solution and preparation method thereof | |
Yu et al. | Schisanhenol improves early porcine embryo development by regulating the phosphorylation level of MAPK | |
CN114196580B (en) | Streptomyces lavendulae Hainan variant strain and method for preparing zhongshengmycin product by using same | |
Liu et al. | Toxic effects of Fusarium mycotoxin butenolide on rat myocardium and primary culture of cardiac myocytes | |
CN113322213B (en) | Lactobacillus paracasei Jlus66 microbial inoculum with function of improving dysmnesia and application | |
CN114317670A (en) | Screening culture medium and preparation method and application thereof | |
CN104844438A (en) | Compounds with tetracyclic fused ring structure, and preparation method and application thereof | |
WO2013063889A1 (en) | Use of multiflora glycoside in preparing anti-hypoxic drug | |
Yu et al. | Cantharis by photosynthetic bacteria biotransformation: Reduced toxicity and improved antitumor efficacy | |
RU2473689C1 (en) | Tick-borne encephalitis virus inhibitor | |
Lee et al. | Red mold rice against hepatic inflammatory damage in Zn-deficient rats | |
Rajapakse et al. | The effect of six substrates on the growth and yield of American oyster mushrooms based on juncao technology | |
CN114591269B (en) | Eremophilane type sesquiterpene and application thereof in preparation of drugs with anti-inflammatory activity | |
CN106176801B (en) | Application of hydrogen sulfide in preparation of medicine for treating inflammatory anemia | |
TW201439318A (en) | A method for culturing Antrodia cinnamomea, a method for manufacturing an Antrodia cinnamomea alcoholic extract and the use of the Antrodia cinnamomea alcoholic extract thereof | |
CN108866145B (en) | Detection step for reducing IPEC-J2 cell apoptosis by saccharomyces cerevisiae and DON interaction and application thereof | |
CN102453686B (en) | Method for inhibiting generation of aflatoxin by using D-glucal | |
US20240199601A1 (en) | Quinone compound and pharmaceutical use thereof | |
AU2021106957A4 (en) | Application of Anchovy Peptide-catechin Conjugate in Improving Memory |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140604 |